Juan Verdejo

760 total citations
15 papers, 576 citations indexed

About

Juan Verdejo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Juan Verdejo has authored 15 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Juan Verdejo's work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Juan Verdejo is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Juan Verdejo collaborates with scholars based in Mexico, Brazil and Spain. Juan Verdejo's co-authors include Raúl Izaguirre, Osvaldo M. Mutchinick, Eduardo Salazar, J. Wouter Jukema, Lisa Tarasenko, Raúl D. Santos, David D. Waters, Michael Messig, Jean Ferrières and Carlos Brotons and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Juan Verdejo

15 papers receiving 545 citations

Peers

Juan Verdejo
Thomas L. Jeanne United States
R. van Domburg Netherlands
Andrew Koren United States
Rebecca Letterer United States
John Corbelli United States
Eugenia Tedeschi-Reiner Croatia
Lisa Tarasenko United States
Sandeep S. Mangalmurti United States
Philip Poole-Wilson United Kingdom
Vasilisa Sazonov United States
Thomas L. Jeanne United States
Juan Verdejo
Citations per year, relative to Juan Verdejo Juan Verdejo (= 1×) peers Thomas L. Jeanne

Countries citing papers authored by Juan Verdejo

Since Specialization
Citations

This map shows the geographic impact of Juan Verdejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Verdejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Verdejo more than expected).

Fields of papers citing papers by Juan Verdejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Verdejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Verdejo. The network helps show where Juan Verdejo may publish in the future.

Co-authorship network of co-authors of Juan Verdejo

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Verdejo. A scholar is included among the top collaborators of Juan Verdejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Verdejo. Juan Verdejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gómez-Álvarez, Enrique, et al.. (2020). The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico. IJC Heart & Vasculature. 29. 100545–100545. 13 indexed citations
2.
3.
González‐Pacheco, Héctor, Luís M. Amezcua‐Guerra, Armando Vázquez-Rangel, et al.. (2015). Levels of High-Density Lipoprotein Cholesterol are Associated With Biomarkers of Inflammation in Patients With Acute Coronary Syndrome. The American Journal of Cardiology. 116(11). 1651–1657. 12 indexed citations
4.
Jukema, J. Wouter, Michael F. Chiang, Jean Ferrières, et al.. (2010). Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2. Current Medical Research and Opinion. 26(11). 2589–2597. 17 indexed citations
5.
Santos, Raúl D., David D. Waters, Lisa Tarasenko, et al.. (2009). Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. American Heart Journal. 158(5). 860–866. 38 indexed citations
6.
Rosas, Martı́n, Gustavo Pastelı́n, Gilberto Vargas‐Alarcón, et al.. (2009). [Clinical guidelines for detection, prevention, diagnosis and treatment of systemic arterial hypertension in Mexico (2008)].. PubMed. 78 Suppl 2. S2–5. 5 indexed citations
7.
Waters, David D., Carlos Brotons, Jean Ferrières, et al.. (2009). Lipid Treatment Assessment Project 2. Circulation. 120(1). 28–34. 261 indexed citations
8.
Rosas, Martı́n, Gustavo Pastelı́n, Gilberto Vargas‐Alarcón, et al.. (2008). Guías clínicas para la detección, prevención, diagnóstico y tratamiento de hipertensión arterial sistémica en México (2008). Revista Portuguesa de Pneumologia. 78. 5–57. 3 indexed citations
9.
Monroy, Óscar Velázquez, Alberto Francisco Rubio Guerra, Juan Verdejo, et al.. (2007). Morbilidad y mortalidad de la enfermedad isquémica del corazón y cerebrovascular en México. 2005. 77(1). 31–39. 19 indexed citations
10.
Monroy, Óscar Velázquez, Alberto Francisco Rubio Guerra, Juan Verdejo, et al.. (2007). [Morbidity and mortality by ischemic heart disease and stroke in Mexico. 2005].. PubMed. 77(1). 31–9. 13 indexed citations
11.
Verdejo, Juan, et al.. (2000). Manejo de la aterosclerosis en fase crónica. Revista Portuguesa de Pneumologia. 70(1). 83–90. 1 indexed citations
12.
Salazar, Eduardo, Raúl Izaguirre, Juan Verdejo, & Osvaldo M. Mutchinick. (1996). Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. Journal of the American College of Cardiology. 27(7). 1698–1703. 138 indexed citations
13.
Verdejo, Juan, et al.. (1986). [Effects of nifedipine in patients with unstable chronic obstructive pulmonary disease].. PubMed. 56(2). 109–16. 2 indexed citations
14.
Lupi‐Herrera, Eulo, et al.. (1985). Hemodynamic Effect of Hydralazine in Interstitial Lung Disease Patients with Cor Pulmonale. CHEST Journal. 87(5). 564–573. 20 indexed citations
15.
Lupi‐Herrera, Eulo, et al.. (1984). Hemodynamic Effect of Hydralazine in Advanced, Stable Chronic Obstructive Pulmonary Disease with Cor Pulmonale. CHEST Journal. 85(2). 156–163. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas L. Jeanne Breakdown of academic impact, for papers by R. van Domburg Breakdown of academic impact, for papers by Andrew Koren Breakdown of academic impact, for papers by Rebecca Letterer Breakdown of academic impact, for papers by John Corbelli Breakdown of academic impact, for papers by Eugenia Tedeschi-Reiner Breakdown of academic impact, for papers by Lisa Tarasenko Breakdown of academic impact, for papers by Sandeep S. Mangalmurti Breakdown of academic impact, for papers by Philip Poole-Wilson Breakdown of academic impact, for papers by Vasilisa Sazonov
Rankless by CCL
2026